2025 fourth_quarter Filing

Life Sciences PA supports a robust NIH budget as well as opportunities for Pennsylvania to maintain its leadership role with continued collaborative grant support including the DOD, EDA and NSF. The NIH is the leading investor worldwide in basic scientific research. This funding supports the crucial first step in life sciences investment through discovery and understanding of human biology and physiology. Pennsylvania research institutions and small companies received more than $2 billion in NIH funding in 2023 and, in many cases, hold contractual agreements with the NIH. This research also leads to spin-out companies and technology transfer that perpetuate the cycle of innovation in the Commonwealth. This cut threatens continued research and development in potential treatments and cures for patients. Life Sciences PA joined Pennsylvania patients and researchers at the Rally for Medical Research encouraging Congress to support the highest possible appropriation increase recommended by the medical research community and to complete the FY2026 appropriations process in a timely manner to avoid additional disruptions to the life sciences ecosystem.

Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Reauthorization Innovative research and the development of groundbreaking medicines, therapeutics and diagnostics is a top priority for life science companies throughout Pennsylvania. These innovations require an abundance of resources, which is why support at both the federal and state levels is important. Many of these companies rely on SBIR (Small Business Innovation Research) funds as a critical component to moving their work forward. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help translate cutting-edge discoveries into real-world solutions - driving economic growth, creating jobs, and improving public health. These programs are currently scheduled to expire September 30, 2025. Life Sciences PA supports the permanent reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, created in 1982 and 1992, respectively. While not life sciences specific, these two programs fund domestic small businesses engaging in research and development on the path to technology commercialization. In 2021, the SBIR program funded more than $30 million in life sciences research in Pennsylvania. This funding has helped many of our small member companies grow and thrive. H.R.5100 INNOVATE Act.